INKT vs ZBH · $59.1M cap vs P/E 23, rev $4.26B
Mink Therapeutics Inc (INKT) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Mink Therapeutics Inc (INKT) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
INKT does not have a complete income-statement cache yet.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
INKT currently screens at market cap $59.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the INKT and ZBH stock pages for the full models.
Not investment advice.